| dc.creator | Dhiman P. | |
| dc.creator | Malik N. | |
| dc.creator | Sobarzo-Sánchez E. | |
| dc.creator | Uriarte E. | |
| dc.creator | Khatkar A. | |
| dc.date.accessioned | 2020-09-02T22:16:17Z | |
| dc.date.accessioned | 2022-11-08T20:21:39Z | |
| dc.date.available | 2020-09-02T22:16:17Z | |
| dc.date.available | 2022-11-08T20:21:39Z | |
| dc.date.created | 2020-09-02T22:16:17Z | |
| dc.date.issued | 2019 | |
| dc.identifier | 24, 3, - | |
| dc.identifier | 14203049 | |
| dc.identifier | https://hdl.handle.net/20.500.12728/4265 | |
| dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5144105 | |
| dc.language | en | |
| dc.publisher | MDPI AG | |
| dc.subject | Flavonoids | |
| dc.subject | In-silico design | |
| dc.subject | Mental disorders | |
| dc.subject | Monoamine oxidase | |
| dc.subject | Monoamine oxidase inhibitors | |
| dc.subject | Neurodegenerative disorder | |
| dc.subject | Quercetin | |
| dc.subject | flavonoid | |
| dc.subject | monoamine oxidase inhibitor | |
| dc.subject | quercetin | |
| dc.subject | animal | |
| dc.subject | chemical phenomena | |
| dc.subject | chemistry | |
| dc.subject | human | |
| dc.subject | mental disease | |
| dc.subject | metabolism | |
| dc.subject | molecular model | |
| dc.subject | neurologic disease | |
| dc.subject | structure activity relation | |
| dc.subject | Animals | |
| dc.subject | Chemical Phenomena | |
| dc.subject | Flavonoids | |
| dc.subject | Humans | |
| dc.subject | Mental Disorders | |
| dc.subject | Models, Molecular | |
| dc.subject | Monoamine Oxidase Inhibitors | |
| dc.subject | Nervous System Diseases | |
| dc.subject | Quercetin | |
| dc.subject | Structure-Activity Relationship | |
| dc.title | Quercetin and related chromenone derivatives as monoamine oxidase inhibitors: Targeting neurological and mental disorders | |
| dc.type | Review | |